EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine

Ayman Elbehiry iD, Eman Marzouk iD, Husam M Edrees, Moustafa H Abdelsalam, Feras Aljizani, Saad Alqarni, Eyad Khateeb, Feras Alzaben, Mai Ibrahem, Ayman M Mousa, Nasser Huraysh, Akram Abu-Okail

Diagnostics · 21.11.2025 · 15 (23) · 2944

DOI: 10.3390/diagnostics15232944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 21.11.2025. Verfasst von Ayman Elbehiry und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bloodstream infections and sepsis necessitate rapid, sensitive, and clinically relevant diagnostics to minimize treatment delays and improve clinical outcomes. Next-generation sequencing enables culture-independent pathogen detection, antimicrobial resistance profiling, and genome-informed epidemiology. This narrative review integrates clinical evidence with practical workflows across three complementary approaches. We describe the use of plasma microbial cell-free DNA for broad organism detection and burden monitoring, as well as metagenomic next-generation sequencing of blood or plasma for unbiased pathogen discovery, including culture-negative and polymicrobial infections. Same-day Oxford Nanopore Technologies sequencing of positive blood culture broth is also discussed as a way to accelerate species identification, targeted resistance reporting, and infection-prevention decisions. We outline the sample-to-result steps, typical turnaround time (TAT), and stewardship-aligned decision points. Analytical reliability depends on effective reduction in human DNA background, stringent control of background and reagent-derived nucleic acids in low-biomass samples, and documented and validated bioinformatics workflows that are supported by curated taxonomic and resistance databases. Quantitative reports should adhere to validated thresholds and should be interpreted in the context of internal controls and clinical pretest probability. Ongoing challenges include variable correlation between genotype and phenotype for specific pathogen and antibiotic pairs, interpretation of low-level signals, and inconsistent regulatory and reimbursement environments. Advances in portable sequencing, faster laboratory and analytical workflows, and scaled liquid biopsy strategies may further reduce the TAT and expand access. Integrating these tools within One Health frameworks and global genomic surveillance programs could support early resistance detection and coordinated public health action, which could help to advance sepsis care toward more precise treatment and real-time infection control insights.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancebloodstream infectionsgenomic epidemiologymetagenomic sequencingmicrobial cell-free DNAnanoporepublic healthsepsis

Autor:innen und Institutionen

  • Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.
  • Department of Physiology, Faculty of Medicine, University of Tabuk, Tabuk 47191, Saudi Arabia.
  • Department of Medical Laboratory, King Fahad Armed Forces Hospital, Jeddah 23311, Saudi Arabia.
  • Department of Family Medicine, King Fahad Armed Forces Hospital, Jeddah 23311, Saudi Arabia.
  • Department of Food Service, King Fahad Armed Forces Hospital, Jeddah 23311, Saudi Arabia.
  • Department of Public Health, College of Applied Medical Science, King Khalid University, Abha 61421, Saudi Arabia.

ORCID-Profile: Ayman Elbehiry, Eman Marzouk

Zitieren

APA

Elbehiry, A., Marzouk, E., Edrees, H. M., Abdelsalam, M. H., Aljizani, F., Alqarni, S., Khateeb, E., Alzaben, F., Ibrahem, M., Mousa, A. M., Huraysh, N., & Abu-Okail, A. (2025). Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine. Diagnostics, 15(23), 2944. https://doi.org/10.3390/diagnostics15232944

Vancouver

Elbehiry A, Marzouk E, Edrees HM, Abdelsalam MH, Aljizani F, Alqarni S, et al. Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine. Diagnostics. 2025;15(23):2944. doi:10.3390/diagnostics15232944

BibTeX
@article{Elbehiry2025,
  author = {Elbehiry, Ayman and Marzouk, Eman and Edrees, Husam M and Abdelsalam, Moustafa H and Aljizani, Feras and Alqarni, Saad and Khateeb, Eyad and Alzaben, Feras and Ibrahem, Mai and Mousa, Ayman M and Huraysh, Nasser and Abu-Okail, Akram},
  title = {Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {23},
  pages = {2944},
  doi = {10.3390/diagnostics15232944}
}
Kostenlos starten →